Home About Us Research & Development Investors & Media Careers Contact Us

News Highlights

March 31, 2014
Concert Pharmaceuticals Reports Year End 2013 Financial Results

March 31, 2014
Concert Pharmaceuticals Announces Filing of its Annual Report on Form 10-K

March 19, 2014
Concert Pharmaceuticals Announces CTP-499 Late Breaking Presentation at the National Kidney Foundation 2014 Spring Clinical Meeting



Welcome to Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company. We apply our extensive knowledge of deuterium chemistry to discover and develop novel small molecule drugs.

Concert in the news... a selection of news stories featuring Concert.

Healthcare Global
With the innovation of implementing deuterium, Concert Pharmaceuticals Inc. is demonstrating itself a pioneer in the world of science. Read more

Issued U.S. Patents

Concert is building a broad patent estate. View List


Concert has presented at a number scientific meetings. View Poster presentations

  ©2009 Concert Pharmaceuticals, Inc.
Design by Digizyme
Home     Sitemap